Advertisement
Screener

INOZYME PHARMA, INC. Patents: Active

INOZYME PHARMA, INC. Active Patents

2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2020-12-03: Application 17111156; Invention METHODS OF TREATING TISSUE CALCIFICATION; Applicant Inozyme Pharma, Inc.; Status Patented Case.
  • 2020-03-18: Application 16648388; Invention METHODS OF IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING A RECOMBINANT ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE (NPP1); Applicant Inozyme Pharma, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2020-12-0317111156METHODS OF TREATING TISSUE CALCIFICATIONInozyme Pharma, Inc.Patented Case2023-05-16RE49529
Anthony Quinn
Nelson Hsia
Tayeba Khan
Kim Lynette Askew
Gregory Grabowski
Zhiliang Cheng
W. Charles O'Neill
United States
United States
United States
United States
United States
United States
United States
CAMPELL, BRUCE R
2020-03-1816648388METHODS OF IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING A RECOMBINANT ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE (NPP1)Inozyme Pharma, Inc.Patented Case2024-11-0512134790US20200263153A1
Tayeba KHAN
Andre MAROZSAN
Kim ASKEW
United States
United States
United States
CHOWDHURY, IQBAL HOSSAIN